Michael Partridge
![Michael Partridge Michael Partridge](https://genetherapy-immunogenicity.com/wp-content/uploads/sites/213/2025/02/Michael-Partridge.jpg)
Company: Regeneron
Job title: Senior Director
Seminars:
12:00PM Fireside Chat: Driving Standardization through Collaborative Pathways to Improve Gene Therapy Outcomes 12:00 pm
• What are the current gaps or barriers to assay standardization in gene therapy? • How can collaboration between industry, academia, and regulatory bodies accelerate the adoption of standardized assays? • Brainstorm ways to ensure standardized assays remain adaptable to evolving therapeutic innovationsRead more
day: Conference Day 2
9:30AM Strategic Approaches to Implement Repeat Dosing 9:30 am
• Develop standardized, sensitive assays to interpret TAb and NAb responses across AAV serotypes, leveraging lessons from companion diagnostics for consistent therapeutic class interpretation • Identify clinically impactful anti-AAV titers, assess the relevance of systemic titers for local therapies, and explore dosing strategies over low-titer responses as seen with Hemegenix • Establish bioanalytical approaches to…Read more
day: Conference Day 1